Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001336 · ClinicalTrials.gov registry record
In Vitro Studies of Immunological and Stem Cell Function in Peripheral Blood Mononuclear Cells in Patients
A clinical trial, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 1,000
- Enrollment target
NCT00001336: Completed study, sponsored by National Cancer Institute (NCI).
NCT00001336 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 1,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00001336 has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 1,000 participants
- Enrollment target
Study Summary
Peripheral blood mononuclear cells (PBMC) will be collected from patients who have leukemia or lymphoma or other medical conditions involving altered lymphohematopoietic stem cell or immunological function. These PBMC will be assessed for cellular markers by flow cytometry and will be studied for in vitro T helper, effector and suppressor cell functions, to determine whether cell mediated immunity is involved in the condition, or indicative of therapeutic efficacy or is predictive for outcome. Peripheral blood stem cells (PBSC) from untreated donors and from cytokine treated donors will be assessed for cellular markers and in vitro growth characteristics that might be useful for identifying normal stem cell populations.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 1993-04 |
| Est. Completion | 2003-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00001336
The ClinicalTrials.gov registry entry for NCT00001336 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00001336 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00001336 about?
NCT00001336 is a clinical study titled "In Vitro Studies of Immunological and Stem Cell Function in Peripheral Blood Mononuclear Cells in Patients". Peripheral blood mononuclear cells (PBMC) will be collected from patients who have leukemia or lymphoma or other medical conditions involving altered lymphohematopoietic stem cell or immunological function. These PBMC will be assessed for cellular markers by flow cytometry and will be studied for in...
What is the current status of trial NCT00001336?
This trial is currently completed. The enrollment target is 1,000 participants. The study started on 1993-04. Estimated completion is 2003-02.
Who is sponsoring clinical trial NCT00001336?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.